TrialThe oncologist2021

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.

Laurent Zelek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.